Voxel S.A. | Income Statement

Fiscal year is January-December. All values PLN Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
103,219.30
102,947.60
132,047.80
120,663.20
152,159.80
170,411.20
Cost of Goods Sold (COGS) incl. D&A
76,963.80
83,314.70
96,072.70
85,557.30
110,504.90
122,063.30
Gross Income
26,255.50
19,632.90
35,975.10
35,105.90
41,654.90
48,347.90
SG&A Expense
21,157.70
20,055.70
18,770.50
19,529.70
18,800.00
19,065.60
EBIT
3,974.50
-
16,231.60
-
22,764.40
29,019.90
Unusual Expense
64.00
183.60
-
-
-
396.90
Non Operating Income/Expense
2,283.90
2,343.30
4,121.60
983.70
2,925.80
2,764.40
Interest Expense
4,064.60
5,184.70
3,214.90
2,573.00
2,572.40
3,001.70
Pretax Income
2,605.20
3,743.60
17,760.00
14,788.40
23,344.90
28,573.30
Income Tax
441.40
788.90
3,424.00
3,786.10
3,542.10
5,742.10
Consolidated Net Income
3,046.60
4,532.50
14,336.00
11,002.30
19,802.80
23,374.20
Net Income
3,017.40
4,532.50
14,336.00
11,002.30
19,802.80
23,374.20
Net Income After Extraordinaries
3,017.40
4,532.50
14,336.00
11,002.30
19,802.80
23,374.20
Net Income Available to Common
3,017.40
4,532.50
14,336.00
11,002.30
19,802.80
23,374.20
EPS (Basic)
0.29
0.43
1.36
1.05
1.89
2.23
Basic Shares Outstanding
10,265.60
10,502.60
10,502.60
10,502.60
10,502.60
10,502.60
EPS (Diluted)
0.32
0.43
1.36
1.05
1.89
2.23
Diluted Shares Outstanding
10,443.80
10,502.60
10,502.60
10,502.60
10,502.60
10,502.60
EBITDA
14,209.90
11,672.60
29,394.90
28,182.00
36,048.80
43,323.90
Other Operating Expense
1,123.30
881.60
973.00
62.50
90.50
262.40
Non-Operating Interest Income
475.40
585.80
621.70
739.00
227.10
187.60
Minority Interest Expense
29.20
-
-
-
-
-

About Voxel

View Profile
Address
ul. Wielicka 265
Kraków MA 30
Poland
Employees -
Website http://www.voxel.pl
Updated 07/08/2019
Voxel SA (Poland) engages in the provision of medical services. It operates through the following segments: Medical Services, Manufacture of Radiopharmaceuticals, Information Technology Products, Equipment, Modern Hospital Facilities, and Medical Facilities. The Medical Services segment offers imaging diagnostics, teleradiology services, and clinical trials.